NEW YORK (360Dx) – Quidel announced today it has received CE marking for a near-patient diagnostic assay for determining troponin I levels as an aid in diagnosing myocardial infarction.

The TriageTrue High Sensitivity Troponin I Test is a single-use fluorescence immunoassay that detects a subunit of the troponin complex released by heart muscle cells after a myocardial infarction. The test is run using whole blood or plasma specimens that have been anticoagulated with EDTA on the Quidel Triage Meter Pro instrument.